Synkinesis: Clinical Trials

10 trials for Synkinesis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 not yet recruiting, 2 unknown, 1 recruiting. 4 Not applicable, 4 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Unknown 2, Completed 1, Not yet recruiting 1
Phase 44Completed 2, Not yet recruiting 1, Withdrawn 1
Phase 31Completed 1

Follow Synkinesis: new trials by email Literature Review of Synkinesis trials Research Report on Synkinesis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mindfulness in Nonflaccid Facial Paralysis
Mindfulness Sessions, No Mindfulness Sessions - Facial Paralysis
Not applicableNot yet recruitingWake Forest University Health Sciences242027-04-012026-09-30
Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis
Botulinum Toxin Type A Injection [Botox] - Synkinesis
Phase 4Not yet recruitingVanderbilt University Medical Center502026-07-012026-04-15
Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis
Apraclonidine - Synkinesis, Facial Nerve Palsy
Phase 4WithdrawnUniversity of Alabama at Birmingham2025-12-012024-07-19
Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis
Oxymetazoline 0.1% (Pf) Oph Soln Ud, Preservative free lubricating drops - Blepharoptosis, Synkinesis
Phase 3CompletedMilton S. Hershey Medical Center362024-01-112026-03-09
Functional Recovery From Facial Paralysis
Selective muscle electrostimulation with exponential current, Facial muscle reeducation in front of the mirror - Peripheral Facial Paralysis, Facial Palsy
Not applicableUnknownUniversidad Nacional del Nordeste, Argentina502023-06-012024-08-01
Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy
Botox injection, Neurotomy - Facial Paralysis, Facial Palsy
Not applicableUnknownRebecka Ohm732022-02-012023-10-06
Kabat Technique and Neuromuscular Effect in Patients With Bell's Palsy
Kabat Technique's, Neuromuscular Re-Education - Bell Palsy
Not applicableCompletedRiphah International University242020-11-152021-03-19
Mixed Methods Investigation of Chronic Facial Paralysis in Individuals With Synkinesis
Neuromuscular Retraining Therapy (4 months), Chemodenervation (4 months), Neuromuscular Retraining + Chemodenervation - Synkinesis
Phase 4CompletedUniversity of Wisconsin, Madison152019-10-242022-09-29
Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis
OnabotulinumtoxinA Injectable Product, AbobotulinumtoxinA Injectable Product, Incobotulinumtoxin A Injectable Product - Facial Nerve Injuries, Facial Paresis Associated With Facial Nerve Dysfunction
Phase 4CompletedUniversity of Utah712012-07-012017-07-31
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies
Congenital Fibrosis of Extraocular Muscles, Duane Retraction Syndrome
RecruitingBoston Children's Hospital200002004-02-012026-02-11

Narrower conditions

Facial Paralysis (6)  ·  Bell Palsy (4)  ·  Abducens Nerve Diseases (1)  ·  Accessory Nerve Diseases (1)  ·  Athabaskan brainstem dysgenesis (1)  ·  Blepharoptosis (1)  ·  Congenital Cranial Dysinnervation Disorders (1)  ·  Duane Retraction Syndrome (1)  ·  Facial Asymmetry (1)  ·  Facial Nerve Injuries (1)  ·  Facial paresis, hereditary, congenital (1)  ·  Glossopharyngeal Nerve Diseases (1)  ·  Hyperkinesis (1)  ·  Hypoglossal Nerve Diseases (1)

Broader conditions

Dyskinesias (10)  ·  Nervous System Diseases (10)  ·  Neurologic Manifestations (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Signs and Symptoms (10)  ·  Mouth Diseases (8)  ·  Stomatognathic Diseases (8)  ·  Paralysis (6)  ·  Cranial Nerve Diseases (5)  ·  Facial Nerve Diseases (5)  ·  DNA Virus Infections (4)  ·  Herpesviridae Infections (4)  ·  Infections (4)  ·  Virus Diseases (4)  ·  Eye Diseases (2)

Interventions

Botulinum Toxins, Type A (4)  ·  incobotulinumtoxinA (2)  ·  Denervation (1)  ·  Nerve Block (1)  ·  Oxymetazoline (1)  ·  abobotulinumtoxinA (1)  ·  apraclonidine (1)

Sponsors

Boston Children's Hospital (1)  ·  Milton S. Hershey Medical Center (1)  ·  Rebecka Ohm (1)  ·  Riphah International University (1)  ·  Universidad Nacional del Nordeste, Argentina (1)  ·  University of Alabama at Birmingham (1)  ·  University of Utah (1)  ·  University of Wisconsin, Madison (1)  ·  Vanderbilt University Medical Center (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (4)  ·  Argentina (1)  ·  Pakistan (1)  ·  Sweden (1)

Top investigators

Benjamin Greene, MD (1)  ·  Birgit Stark, MD, PhD (1)  ·  Dr Aruba Saeed, PHD* (1)  ·  Elizabeth Engle, MD (1)  ·  Jessyka Lighthall, MD (1)  ·  Katherine Gossett, MD (1)  ·  Preston D Ward, MD (1)  ·  Priyesh Patel, MD (1)  ·  Scott R Chaiet, MD (1)

Results publications

PMID 28973094